Provectus Biopharmaceuticals, Inc. (PVCT) is a biopharmaceutical company engaged in developing ethical pharmaceuticals for oncology and dermatology indications.
Location: United States, Tennessee, Knoxville
Employees: 51-200
Investors 1
| Date | Name | Website |
| - | Centrecour... | centrecour... |
Mentions in press and media 2
| Date | Title | Description |
| 26.11.2012 | Repurposed diagnostic agent nears phase 3 trials as a treatment for melanoma | Although the Knoxville, Tennessee company doesn’t elaborate much on its immunotherapy’s mechanism of action, it says PV-10 is injected into lesions to selectively target and destroy cancer without harming healthy tissue. In phase 2 trials, ... |
| - | Repurposed diagnostic agent nears phase 3 trials as a treatment for melanoma | A compound used for years as a diagnostic agent for liver and eye cancer is nearing phase 3 clinical trials for a different purpose: to treat cancers and dermatological conditions. Provectus Pharmaceuticals Inc. (OTC BB:PVCT) is developing ... |